Individualized ATG Dosing in HSCT
Researchers found that combining arsenic trioxide with corticosteroids (CS) yielded a high response rate and rapid CS dose
PTCy-based regimens appeared to significantly improve GVHD-free relapse-free survival
Ruxolitinib therapy for steroid-refractory GVHD appeared to be more effective in patients with low-grade disease and ...
The complex pathology of acute GVHD and what features are notable.
Latest data on patients’ perception of caregiver burden after an allogeneic SCT, potential implications for oncology ...
The addition of mesenchymal stromal cells (MSCs) to second-line SR aGVHD therapy with basiliximab and a calcineurin inhibitor
Cyclosporine A with posttransplant cyclophosphamide, significantly improved GVHD-free, relapse-free survival
The basics of PTCy after hematopoietic cell transplantation for GVHD prevention, plus, how nurses can explain PTCy to patient
Extracorporeal photopheresis for the treatment of chronic GVHD was well-tolerated and appeared to improve overall survival.
The co-infusion of unrelated cord blood during hematopoietic stem cell transplantation appeared to improve GVHD outcomes.
Recent research related to PTCy highlights the importance of diversity in clinical trials.
Nurses need to be proficient in using tools like the Rule of Nines to determine the body surface area affected by skin GVHD.
Patients who receive a transplant at a young age may experience GVHD symptoms decades later, like oral chronic GVHD.
According to a recent report in the Journal of Clinical Oncology, chronic graft-versus-host disease treatments that did not ...
Some allogeneic patients receive a donor graft that has been T-cell depleted in the laboratory as a method to prevent or ...
Oncology nurses need to be aware that more survivors are developing chronic graft-versus-host disease (cGVHD)...
Four variables for cGVHD may help transplant teams consider early discontinuation of immunosuppressants in the future.
Jennifer Whangbo and collaborating researchers explored a combination of low-dose interleukin-2 (LD IL-2) and regulatory T ...
In a study led by Nikolett Lupsa, researchers aimed to address the unmet need in accurate predictive factors for acute ...